10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $866,250 | +267.1% | 21,000 | +577.4% | 0.16% | +258.7% |
| Q1 2022 | $236,000 | -48.9% | 3,100 | 0.0% | 0.05% | -54.5% |
| Q4 2021 | $462,000 | +2.4% | 3,100 | 0.0% | 0.10% | +2.0% |
| Q3 2021 | $451,000 | -25.7% | 3,100 | 0.0% | 0.10% | -21.4% |
| Q2 2021 | $607,000 | -67.0% | 3,100 | -85.0% | 0.13% | -73.1% |
| Q2 2020 | $1,840,000 | -4.0% | 20,600 | -33.0% | 0.47% | -9.1% |
| Q1 2020 | $1,916,000 | -39.1% | 30,750 | -25.5% | 0.52% | -48.5% |
| Q4 2019 | $3,145,000 | +21.1% | 41,250 | -19.9% | 1.00% | +36.2% |
| Q3 2019 | $2,596,000 | – | 51,500 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |